Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Healthcare Biotechnology

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc > My God

<< Previous

Bullboard Posts

Next >>

Comment by bluebeard123on Aug 17, 2021 2:47pm

103 Views

Post# 33717997

RE:RE:RE:RE:RE:RE:My God

It would be interesting to know if there is still any merit to the covid-19 nasal test technology. It appeared to more testing could be done before making a decision to drop this. Maybe even do a joint venture to reduce financial risk?

<< Previous

Bullboard Posts

Next >>

@ the Bell: TSX advances to start off Christmas trading week